MEDICINA MOLECULAR
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (43)
2024
-
Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers
British Journal of Surgery, Vol. 111, Núm. 3
-
TRIM33 loss in multiple myeloma is associated with genomic instability and sensitivity to PARP inhibitors
Scientific Reports, Vol. 14, Núm. 1
2023
-
DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
Cancers, Vol. 15, Núm. 2
-
Predominantly Pro-Inflammatory Phenotype with Mixed M1/M2 Polarization of Peripheral Blood Classical Monocytes and Monocyte-Derived Macrophages among Patients with Excessive Ethanol Intake
Antioxidants, Vol. 12, Núm. 9
2022
-
A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions
Cell Death and Differentiation, Vol. 29, Núm. 12, pp. 2347-2361
-
New functions of C3G in platelet biology: Contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance
Frontiers in Cell and Developmental Biology, Vol. 10
-
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Experimental Hematology and Oncology, Vol. 11, Núm. 1
2021
-
Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins
Haematologica, Vol. 106, Núm. 1, pp. 142-153
-
Granuloma formation in a cyba-deficient model of chronic granulomatous disease is associated with myeloid hyperplasia and the exhaustion of B-cell lineage
International Journal of Molecular Sciences, Vol. 22, Núm. 16
2020
-
A missense in HSF2BP causing primary ovarian insufficiency affects meiotic recombination by its novel interactor c19orf57/brme1
eLife, Vol. 9, pp. 1-93
-
Cutaneous squamous cell carcinoma: From biology to therapy
International Journal of Molecular Sciences, Vol. 21, Núm. 8
-
FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 7, pp. 4171-4182
-
Meiotic chromosome synapsis depends on multivalent SYCE1-SIX6OS1 interactions that are disrupted in cases of human infertility
Science Advances, Vol. 6, Núm. 36
2019
-
Factors regulating microRNA expression and function in multiple myeloma
Non-coding RNA, Vol. 5, Núm. 1
-
MEK5 promotes lung adenocarcinoma
The European respiratory journal
-
Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency
PLoS ONE, Vol. 14, Núm. 5
-
Ubiquitin-specific protease 26 (USP26) is not essential for mouse gametogenesis and fertility
Chromosoma, Vol. 128, Núm. 3, pp. 237-247
2017
-
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
Journal of Hematology and Oncology, Vol. 10, Núm. 1
-
Targeting ongoing DNA damage in multiple myeloma: Effects of DNA damage response inhibitors on plasma cell survival
Frontiers in Oncology, Vol. 7, Núm. MAY
-
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040